Safety and Effectiveness of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Renal Dysfunction in Taiwan
博士 === 國立成功大學 === 臨床藥學與藥物科技研究所 === 103 === Background: Stroke is the third leading cause of death and first leading cause of adult disability, while acute ischemic stroke (AIS) is the most common type of stroke in Taiwan. Intravenous thrombolytic therapy with recombinant tissue-type plasminogen acti...
Main Authors: | Cheng-YangHsieh, 謝鎮陽 |
---|---|
Other Authors: | Yea-Huei Kao Yang |
Format: | Others |
Language: | en_US |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/79964558346532971440 |
Similar Items
-
Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
by: Semai Bek, et al.
Published: (2009-12-01) -
Intravenous thrombolytic therapy in acute ischemic stroke: Experiences of Adıyaman
by: Ali Arık, et al.
Published: (2020-12-01) -
Intravenous Thrombolytic Therapy in Acute Ischemic Stroke: The Experience of Kütahya
by: Mustafa Çetiner, et al.
Published: (2017-12-01) -
Intravenous thrombolytic therapy in acute ischemic stroke: The art and science of treatment decision making
by: Sylaja P, et al.
Published: (2008-01-01) -
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke: Experiences of a Tertiary Hospital in Turkey
by: Murat Yilmaz, et al.
Published: (2021-03-01)